8
當(dāng)前位置：北京百奧創(chuàng)新科技有限公司>>Gibco>> 19993013Gibco™ MEM Rega-3
Gibco™ MEM Rega-3
Gibco™ MEM, developed by Harry Eagle, was based on his earlier formulation of Basal Medium Eagle (BME). Many other modifications of MEM followed, including this Rega-3 modification. MEM Rega-3 is unique because it has a reduced sodium bicarbonate concentration, modified salt concentrations, and contains the antibiotic gentamycin sulfate. This product is made with Earle’s salts.
Product Use:
For Research Use Only: Not intended for animal or human diagnostic or therapeutic use.
cGMP Manufacturing and Quality System:
Gibco™ MEM is manufactured at a cGMP compliant facility located in Paisley, Scotland, UK. The facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.
MEM Rega-3 contains no proteins, lipids, or growth factors. Therefore, MEM Rega-3 requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). MEM uses a sodium bicarbonate buffer system (0.85 g ? L) and therefore requires a low CO2 environment to maintain physiological pH.
